bevacizumab,RGX-202-01
roche,Inspirna
#inspirna to present phase 1b #rgx20201 clinical trial data at the #esmogastrointestinalcancer22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.